• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Hippo/YAP信号通路的激活通过上调Foxm1加剧血管重塑并加重高血压。

Activation of Hippo/YAP signaling pathway exacerbates vascular remodeling and aggravates hypertension by upregulating Foxm1.

作者信息

Bai Jing, Yang Yujuan

机构信息

Department of Geriatric Cardiovascular Medicine, Shaanxi Provincial People's Hospital, No. 256, Youyi West Road, Xi'an, 710068, China.

出版信息

J Mol Histol. 2025 May 19;56(3):158. doi: 10.1007/s10735-025-10443-1.

DOI:10.1007/s10735-025-10443-1
PMID:40388085
Abstract

The Hippo/YAP signaling pathway is closely related to the occurrence and development of cardiovascular diseases. However, it's still unclear whether this pathway plays a certain role in hypertension. In this study, aortic morphology and function in spontaneously hypertensive rats (SHR) were comprehensively evaluated using Wistar-Kyoto rats (WKY) as controls. Results indicated that the aorta of SHRs have distinct changes in pathological structure. Furthermore, the proliferative activity of vascular smooth muscle cells (VSMCs) was enhanced, with vascular fibrosis being aggravated. Immunohistochemical analysis revealed that SHRs exhibited high expression of Yes-Associated Protein (YAP). Western Blot analysis showed that cytoplasmic YAP and TAZ expression decreased in hypertensive rats, indicating that YAP/TAZ nuclear transfer increased and Hippo/YAP signaling pathway had been activated. The cell function experiments of VSMCs extracted from rat aorta showed that the cell viability and proliferation ability of VSMCs in SHRs were enhanced, the expression of Fibronectin and collagen I was increased, and vascular fibrosis was aggravated. siRNA-YAP (si-YAP) can reverse the above phenomenon in VSMCs. Knockdown of YAP can inhibit Foxm1 expression. As an inhibitor of large tumor suppressor kinases LAST1/2, GA-107 can inhibit the phosphorylation level of YAP, increase blood pressure, aggravate aortic pathomorphological changes, promote VSMCs proliferation and vascular fibrosis, and thus aggravate hypertension symptoms in SHRs. However, these effects of GA-107 can be antagonized by inhibiting Foxm1 with thiosulfathiazole (Thio). Conclusively, Hippo/YAP signaling pathway promotes vascular remodeling through the regulation of Foxm1 and causes hypertension.

摘要

河马/Yes相关蛋白(YAP)信号通路与心血管疾病的发生和发展密切相关。然而,该通路在高血压中是否发挥一定作用仍不清楚。在本研究中,以Wistar-Kyoto大鼠(WKY)作为对照,全面评估了自发性高血压大鼠(SHR)的主动脉形态和功能。结果表明,SHR的主动脉病理结构有明显改变。此外,血管平滑肌细胞(VSMC)的增殖活性增强,血管纤维化加重。免疫组织化学分析显示,SHR中Yes相关蛋白(YAP)表达较高。蛋白质印迹分析表明,高血压大鼠细胞质中YAP和转录共激活因子TAZ表达降低,表明YAP/TAZ核转位增加,河马/YAP信号通路被激活。从大鼠主动脉提取的VSMC细胞功能实验表明,SHR中VSMC的细胞活力和增殖能力增强,纤连蛋白和I型胶原表达增加,血管纤维化加重。小干扰RNA-YAP(si-YAP)可逆转VSMC中的上述现象。敲低YAP可抑制叉头框蛋白M1(Foxm1)表达。作为大肿瘤抑制激酶LAST1/2的抑制剂,GA-107可抑制YAP的磷酸化水平,升高血压,加重主动脉病理形态学改变,促进VSMC增殖和血管纤维化,从而加重SHR的高血压症状。然而,GA-107的这些作用可被硫代磺胺噻唑(Thio)抑制Foxm1所拮抗。总之,河马/YAP信号通路通过调节Foxm1促进血管重塑并导致高血压。

相似文献

1
Activation of Hippo/YAP signaling pathway exacerbates vascular remodeling and aggravates hypertension by upregulating Foxm1.Hippo/YAP信号通路的激活通过上调Foxm1加剧血管重塑并加重高血压。
J Mol Histol. 2025 May 19;56(3):158. doi: 10.1007/s10735-025-10443-1.
2
Vascular smooth muscle-specific LRRC8A knockout ameliorates angiotensin II-induced cerebrovascular remodeling by inhibiting the WNK1/FOXO3a/MMP signaling pathway.血管平滑肌特异性 LRRC8A 敲除通过抑制 WNK1/FOXO3a/MMP 信号通路改善血管紧张素Ⅱ诱导的脑血管重塑。
Acta Pharmacol Sin. 2024 Sep;45(9):1848-1860. doi: 10.1038/s41401-024-01280-1. Epub 2024 May 8.
3
Sex differences and role of lysyl oxidase-like 2 in angiotensin II-induced hypertension in mice.赖氨酸氧化酶样蛋白 2 在血管紧张素Ⅱ诱导的小鼠高血压中的性别差异和作用。
Am J Physiol Heart Circ Physiol. 2024 Sep 1;327(3):H642-H659. doi: 10.1152/ajpheart.00110.2024. Epub 2024 Jul 19.
4
Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.乙酰胞苷通过 N-乙酰基转移酶 10 修饰 Amotl1 导致心肌梗死后小鼠心脏成纤维细胞的过度扩张。
Acta Pharmacol Sin. 2024 Jul;45(7):1425-1437. doi: 10.1038/s41401-024-01306-8. Epub 2024 Jun 5.
5
Resveratrol Inhibits Abdominal Aortic Aneurysm Progression by Reducing Extracellular Matrix Degradation, Apoptosis, Autophagy, and Inflammation of Vascular Smooth Muscle Cells via Upregulation of HMOX1.白藜芦醇通过上调血红素加氧酶1(HMOX1)减少细胞外基质降解、细胞凋亡、自噬及血管平滑肌细胞炎症反应,从而抑制腹主动脉瘤进展。
J Endovasc Ther. 2023 Oct 3:15266028231202727. doi: 10.1177/15266028231202727.
6
SLAMF9 aggravates myocardial ischemia reperfusion injury through activating the hippo-yap pathway.信号淋巴细胞激活分子家族成员9(SLAMF9)通过激活河马-Yes相关蛋白(Hippo-YAP)信号通路加重心肌缺血再灌注损伤。
Biochim Biophys Acta Gen Subj. 2025 Jul;1869(8):130821. doi: 10.1016/j.bbagen.2025.130821. Epub 2025 May 16.
7
STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis.STK3是YAP1的转录靶点,也是胃癌发生过程中Hippo信号通路与Wnt信号通路相互作用的核心组成部分。
Mol Cancer. 2025 Jul 2;24(1):186. doi: 10.1186/s12943-025-02391-x.
8
HIF-1α mediates hypertension and vascular remodeling in sleep apnea via hippo-YAP pathway activation.缺氧诱导因子-1α通过激活河马-Yes相关蛋白(Hippo-YAP)信号通路介导睡眠呼吸暂停中的高血压和血管重塑。
Mol Med. 2024 Dec 28;30(1):281. doi: 10.1186/s10020-024-00987-5.
9
TEAD-targeting small molecules induce a cofactor switch to regulate the Hippo pathway.靶向TEAD的小分子诱导辅因子转换以调节Hippo信号通路。
Proc Natl Acad Sci U S A. 2025 Jul 8;122(27):e2425984122. doi: 10.1073/pnas.2425984122. Epub 2025 Jul 3.
10
Mitochondrial Calcium Uniporter-Mediated Regulation of the SIRT3/GSK3β/β-Catenin Signaling Pathway in Vascular Remodeling.线粒体钙单向转运体介导的血管重塑中SIRT3/GSK3β/β-连环蛋白信号通路的调控
FASEB J. 2025 Jul 15;39(13):e70761. doi: 10.1096/fj.202500369RR.

本文引用的文献

1
Transcriptional regulation of CYR61 and CTGF by LM98: a synthetic YAP-TEAD inhibitor that targets in-vitro vasculogenic mimicry in glioblastoma cells.LM98对CYR61和CTGF的转录调控:一种靶向胶质母细胞瘤细胞体外血管生成拟态的合成YAP-TEAD抑制剂。
Anticancer Drugs. 2024 Sep 1;35(8):709-719. doi: 10.1097/CAD.0000000000001627. Epub 2024 Jun 18.
2
Verteporfin induces lipid peroxidation and ferroptosis in pancreatic cancer cells.维替泊芬诱导胰腺癌细胞发生脂质过氧化和铁死亡。
Free Radic Biol Med. 2024 Feb 20;212:493-504. doi: 10.1016/j.freeradbiomed.2024.01.003. Epub 2024 Jan 4.
3
Paediatric blood pressure percentiles from United States of America electronic health records.
来自美国电子健康记录的儿科血压百分位数。
EBioMedicine. 2024 Jan;99:104913. doi: 10.1016/j.ebiom.2023.104913. Epub 2023 Dec 12.
4
Gut microbiome and metabolome in aneurysm rat with hypertension after ginsenoside Rb1 treatment.人参皂苷Rb1治疗后高血压动脉瘤大鼠的肠道微生物群和代谢组
Front Pharmacol. 2023 Nov 23;14:1287711. doi: 10.3389/fphar.2023.1287711. eCollection 2023.
5
The role of angiotensin II activation of yes-associated protein/PDZ-binding motif signaling in hypertensive cardiac and vascular remodeling.血管紧张素 II 激活 yes 相关蛋白/PDZ 结合基序信号在高血压心脏和血管重构中的作用。
Eur J Pharmacol. 2024 Jan 5;962:176252. doi: 10.1016/j.ejphar.2023.176252. Epub 2023 Dec 5.
6
The association between atherogenic index of plasma and all-cause mortality and cardiovascular disease-specific mortality in hypertension patients: a retrospective cohort study of NHANES.在高血压患者中,血浆致动脉粥样硬化指数与全因死亡率和心血管疾病特异性死亡率的关系:NHANES 的回顾性队列研究。
BMC Cardiovasc Disord. 2023 Sep 11;23(1):452. doi: 10.1186/s12872-023-03451-0.
7
Future treatments in hypertension: Can we meet the unmet needs of patients?高血压的未来治疗方法:我们能否满足患者的未满足需求?
Eur J Intern Med. 2023 Sep;115:18-28. doi: 10.1016/j.ejim.2023.06.008. Epub 2023 Jun 17.
8
Association of diabetes, hypertension, and their combination with basal symptoms and treatment responses in overactive bladder patients.糖尿病、高血压及其合并症与膀胱过度活动症患者基础症状及治疗反应的关联
Front Pharmacol. 2023 Mar 30;14:1144470. doi: 10.3389/fphar.2023.1144470. eCollection 2023.
9
Aqueous extract of reduces blood pressure through inhibiting oxidative stress, inflammation and fibrosis of adventitia in primary hypertension.[提取物名称]的水提取物通过抑制原发性高血压中外膜的氧化应激、炎症和纤维化来降低血压。
Front Pharmacol. 2023 Feb 28;14:1093669. doi: 10.3389/fphar.2023.1093669. eCollection 2023.
10
MKL1 fuels ROS-induced proliferation of vascular smooth muscle cells by modulating FOXM1 transcription.MKL1 通过调节 FOXM1 转录促进 ROS 诱导的血管平滑肌细胞增殖。
Redox Biol. 2023 Feb;59:102586. doi: 10.1016/j.redox.2022.102586. Epub 2022 Dec 29.